Should Boston Scientific Stock Be in Your Portfolio Right Now?
BSX's global expansion and MedSurg growth boost Q2 momentum, though currency and macro headwinds weigh on the same.
Insights Into Phibro ( PAHC ) Q4: Wall Street Projections for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Phibro (PAHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Oculis Holding AG ( OCS ) Reports Q2 Loss, Beats Revenue Estimates
Oculis Holding AG (OCS) delivered earnings and revenue surprises of -11.32% and +28.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Should Quest Diagnostics Stock Be in Your Portfolio Right Now?
DGX drives growth with advanced diagnostics, acquisitions and cost savings, but rising debt and macro risks weigh on its outlook.
PAHC vs. BSX: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health ( PAHC Quick QuotePAHC - ) and Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
Should Value Investors Buy Phibro Animal Health ( PAHC ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Phibro Animal Health Corporation ( PAHC ) Hits Fresh High: Is There Still Room to Run?
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PAHC Stock Up 76.4% in a Year: What's Driving the Rally?
Phibro Animal Health's 76.4% stock surge is fueled by strong sales recovery, global growth and a robust balance sheet.
Phibro ( PAHC ) is an Incredible Growth Stock: 3 Reasons Why
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Fortress Biotech ( FBIO ) Reports Q2 Loss, Beats Revenue Estimates
Fortress Biotech (FBIO) delivered earnings and revenue surprises of -48.39% and +13.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Alvotech ( ALVO ) Q2 Earnings and Revenues Beat Estimates
Alvotech (ALVO) delivered earnings and revenue surprises of +153.85% and +50.56%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Haemonetics ( HAE ) Q1 Earnings and Revenues Surpass Estimates
Haemonetics (HAE) delivered earnings and revenue surprises of +8.91% and +5.97%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Curaleaf Holdings, Inc. ( CURLF ) Reports Q2 Loss, Misses Revenue Estimates
Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +14.29% and -0.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
PAHC vs. LMAT: Which Stock Is the Better Value Option?
Are Investors Undervaluing Phibro Animal Health ( PAHC ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Reasons Growth Investors Will Love Phibro ( PAHC )
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
ResMed Inc. ( RMD ) Hit a 52 Week High, Can the Run Continue?
ResMed (RMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Best Growth Stocks to Buy for July 23rd
PAHC, AFYA and ROAD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 23, 2025.
Best Value Stocks to Buy for July 23rd
NX, OPBK and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 23, 2025.
Why Phibro Animal Health ( PAHC ) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Beat the Market the Zacks Way: Curtiss-Wright, Oracle, Starbucks in Focus
CW surged 26% after a Zacks upgrade, while ORCL and SBUX powered portfolio gains in a volatile, inflation-watched market.
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
ARAY rides strong global demand and CyberKnife momentum, but order declines and backlog pressure temper the outlook.
Should You Add Edwards Lifesciences Stock to Your Portfolio Now?
EW gains traction with surgical tech and TAVR growth, but macro pressures and FX headwinds weigh on margins.
Elevance Health Q2 Earnings Miss Estimates on Rising Medical Costs
ELV's Q2 EPS slides 12.6% y/y and misses estimates as rising Medicaid and ACA costs weigh on the results.
ZBH Stock Set to Benefit From New Monogram Technologies Buyout Deal
Zimmer Biomet eyes long-term gains with the $177M Monogram buyout, aiming to expand its robotic knee surgery offerings by 2027.
Should Value Investors Buy Phibro Animal Health ( PAHC ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Growth Stocks to Buy for July 17th
QFIN, AFYA and PAHC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 17, 2025.
3 Reasons Why Growth Investors Shouldn't Overlook Phibro ( PAHC )
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now
XRAY gains traction with digital implants, R&D strength, and Q1 margin growth despite softness in Europe.
PAHC or BSX: Which Is the Better Value Stock Right Now?
PAHC vs. BSX: Which Stock Is the Better Value Option?
Encompass Health Opens Rehabilitation Hospital in Florida
EHC opens its 23rd Florida rehab hospital in Daytona Beach, boosting access to care and supporting its 2025 growth plan.
Should You Continue to Hold Veracyte Stock in Your Portfolio Now?
VCYT's Decipher growth and strong cash position bolster its outlook, but Biopharma headwinds and macro risks loom.
BD Partners With Waters to Build High-Volume Diagnostics Leader
BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.
Best Growth Stocks to Buy for July 15th
QFIN, AFYA and PAHC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 15, 2025.
4 Stocks Trading Near 52-Week High With More Upside Potential
Stocks like KD, FIX, PAHC and DB are seeing price strength and have a high chance of carrying the momentum forward.
Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms
BIO surges 4% as the Stilla acquisition fuels the launch of four ddPCR systems, expanding to 400K+ assay offerings.
Here's Why Phibro Animal Health ( PAHC ) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Phibro Animal Health ( PAHC ) is a Great Momentum Stock: Should You Buy?
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Should You Continue to Hold STERIS Stock in Your Portfolio Now?
STE rides on strong Healthcare and AST growth, but macro pressures and customer consolidation cloud its outlook.
Best Growth Stocks to Buy for July 10th
GOOS, PAHC and DELL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 10, 2025.
Invest in 4 Winning Stocks With Proven Relative Price Power
DELL, JBL, PAHC, and HBM are showing strong relative price strength and upward earnings estimates amid a rising market.
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?
TMO's growth via acquisitions and product launches is strong, but macro pressures and FX headwinds cloud the outlook.
Paysafe and Champion Homes have been highlighted as Zacks Bull and Bear of the Day
PSFE earns Bull of the Day with deep value and rising earnings, while SKY's short surge and weak outlook land it as Bear of the Day.
Phibro ( PAHC ) Soars 6.8%: Is Further Upside Left in the Stock?
Phibro (PAHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Best Growth Stocks to Buy for July 8th
STRT, PAHC and AFYA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 8, 2025.
Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost - Phibro Animal Health ( NASDAQ:PAHC )
JPMorgan upgrades Phibro Animal Health citing strong FY2025 performance and upside potential. Analyst expects healthy FY2026 growth in MFAs, vaccines and nutritional specialties. Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On
U.S. Bancorp To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday - ASGN ( NYSE:ASGN ) , Chubb ( NYSE:CB )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. JP Morgan raised Phibro Animal Health Corporation PAHC price target from $25 to $35.
Top 2 Health Care Stocks That May Plunge This Month - Apogee Therapeutics ( NASDAQ:APGE ) , Phibro Animal Health ( NASDAQ:PAHC )
As of July 7, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices ...
This Constellation Brands Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday - Oscar Health ( NYSE:OSCR ) , Phibro Animal Health ( NASDAQ:PAHC )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Jefferies analyst Kaumil Gajrawala upgraded the rating for Constellation Brands, Inc.
Quest Diagnostics Stock Climbs 27.3% in a Year: What's Fueling It?
DGX stock surges 27.3% in a year, fueled by Advanced Diagnostics, key acquisitions and expanding health plan ties.
